Page last updated: 2024-09-04

rupatadine and Dengue

rupatadine has been researched along with Dengue in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dissanayake, H; Gangani, C; Gomes, L; Gunasinghe, D; Idampitiya, D; Jayarathna, G; Jeewandara, C; Mahapatuna, SD; Malavige, GN; Narangoda, E; Ogg, GS; Perera, Y; Prathapan, S; Sahabandu, P; Vimalachandran, V; Wanigatunga, C; Wickramanayake, S; Wijewickrama, A1
Aman, SAB; Dissanayake, H; Fernando, S; Ginneliya, A; Gomes, L; Idampitiya, D; Jeewandara, C; John, AS; Madushanka, P; Malavige, GN; Ogg, GS; Paranavitane, S; Prathapan, S; Punchihewa, C; Samarasekara, S; Wanigatunga, C; Wijewickrama, A1

Trials

1 trial(s) available for rupatadine and Dengue

ArticleYear
Efficacy of rupatadine in reducing the incidence of dengue haemorrhagic fever in patients with acute dengue: A randomised, double blind, placebo-controlled trial.
    PLoS neglected tropical diseases, 2022, Volume: 16, Issue:6

    Topics: Animals; Cyproheptadine; Dengue; Double-Blind Method; Humans; Incidence; Mice; Severe Dengue; Treatment Outcome

2022

Other Studies

1 other study(ies) available for rupatadine and Dengue

ArticleYear
A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection.
    Scientific reports, 2018, 03-01, Volume: 8, Issue:1

    Topics: Acute Disease; Adult; Animals; Anti-Allergic Agents; Blood Platelets; Cyproheptadine; Dengue; Dengue Virus; Disease Models, Animal; Double-Blind Method; Endothelium; Female; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Preliminary Data; Sri Lanka; Treatment Outcome

2018